Company: RPTX
Filing Date: 2025-12-03
Form Type: PREM14A
Source: 0001193125-25-306948
Chunk: 161

Company: Repare Therapeutics Inc.
Filing Date: 2025-12-03
Form: PREM14A
Chunk 161
---
-shareexercise price that is equal to or greater than the Cash Amount) will be immediately canceled at the Effective Time without any payment and neither the Company nor the Purchaser will be obligated to pay the holder of out-of-the-moneyOptions any consideration in respect of such Options. Currently, Options with an exercise price per share that is less than the Cash Amount of $1.82 are expected to be in-the-moneyat the Effective Time, and Options with an exercise price per share equal to or greater than the Cash Amount of $1.82 are expected to be out-of-the-money. Other than with respect to certain Options held by Mr. Segal, Dr. Zinda, Mr. Forte and Ms. Alves, each Option that is outstanding as of the Effective Time and is held by a Company director or executive officer was granted with a per share exercise price that is greater than the Cash Amount and is an out-of-the-moneyOption. As such, no amounts are expected to be payable to the Company’s directors and executive officers in respect of Options, other than with respect to Mr. Segal, Dr. Zinda, Mr. Forte and Ms. Alves. The following table sets forth for Mr. Segal, Dr. Zinda, Mr. Forte and Ms. Alves, (i) the number of vested and unvested in-the-moneyOptions held as of November 25, 2025; (ii) the cash consideration payable for these in-the-moneyOptions, and (iii) the potential CVR payments that would be payable with respect to CVRs issued in respect of these in-the-moneyOptions. The determination of whether an Option is in-the-moneyor out-of-the-moneyis made as of November 25, 2025 and does not take into account any disposition which may be completed after such date.

| Name                 |     | In the Money 
 Options      
 (vested)     
 (#)          |         |     | Cash Amount for 
 vested In the   
 Money Options   
 ($)             |        |     | In the Money 
 Options      
 (unvested)   
 (#)          |         |     | Cash Amount for 
 unvested In the 
 Money Options   
 ($)             |         |     | Potential Cash   
 Payment for CVRs 
 Issued with      
 Respect          
 to In the Money  
 Options          
 (vested          
 and              
 unvested)        
 ($)              |   |
| Lloyd Segal          |     |              | 188,039 |     |